-
Theory-Mechanism-Clinical, multi-target intervention of Jinlida granule has significant effect on diabetes
Time of Update: 2021-04-19
gave an in-depth explanation on the prevention and treatment of diabetes and the clinical application of Jinlida granules guided by collateral disease theory. The audience brought a wonderful academic feast. This article
-
There is no scientific basis for proper drinking to protect cardiovascular system
Time of Update: 2021-04-19
Since few women drink alcohol and the correlation between genotype and alcohol intake is not very strong, no association has been observed between drinking and blood pressure, stroke or myocardial infarction.
-
Analyzing the risk of cardiovascular disease from a genetic perspective (1): From the liver to the heart
Time of Update: 2021-04-19
If a person carries a risk gene, it will generally be reflected from three blood test indicators, which are: 1) low-density cholesterol (LDL-C); 2) high-density cholesterol (HDL-C); 3) lipoprotein a (Lp(a)).
-
BridGene, a small molecule drug developed for the "unable to drug" target, reached a cooperation with Takeda
Time of Update: 2021-04-19
new drug discovery projects, using BridGene's proprietary IMTAC chemical proteomics platform to discover new targets and small molecule drug candidates for Takeda, and Takeda will advance these drug candidates into the clinical development stage
-
AbbVie's Rinvoq application for the treatment of moderate to severe atopic dermatitis has been delayed by the FDA
Time of Update: 2021-04-19
CompilationFan DongdongA few days ago, the US FDA stated that it would postpone the decision date of Rinvoq's sNDA application for moderate to severe atopic dermatitis by 3 months.
-
JAMA: The protective effect of vaccines against key mutations of the new coronavirus is much higher than that of natural infections
Time of Update: 2021-04-19
virus strain, was modified from the laboratory and contains mutations in the key receptor binding domain of the S protein of multiple emerging mutant strains. >The research team conducted a live virus
-
Bairen Medical: Application for registration of non-stent bioprosthesis and valved pipeline products has been accepted
Time of Update: 2021-04-19
On March 29, Bairen Medical announced that the company's product under development-stent-free bioprosthesis and valved pipeline product, submitted its registration application and was officially accepted by the National Medical Products Administration.
-
Johnson & Johnson BCMA/CD3 dual antibody application for clinical application
Time of Update: 2021-04-19
On April 1, the CDE official website showed that the clinical trial application of Johnson & Johnson's BCMA/CD3 bispecific antibody Teclistamab injection (acceptance number: JXSL2101002/3) was accepted by the CDE.
-
The world's fifth CAR-T is approved, BMS and Gilead each have two equal shares, Novartis is surpassed
Time of Update: 2021-04-19
On March 27, the FDA official website announced that it had approved Abecma, the first CAR-T cell therapy targeting BCMA for the treatment of multiple myeloma (MM) in adults.
-
The first CAR-T therapy targeting BCMA was approved by the FDA for marketing
Time of Update: 2021-04-19
The study recruited 127 patients with relapsed/refractory multiple myeloma who had previously received at least third-line treatment including immunomodulators, proteasome inhibitors, and anti-CD38 antibodies.
-
Brazilian experts warn that more aggressive virus variants may appear at any time
Time of Update: 2021-04-19
On January 10 this year, the Japanese government stated that a new variant of the new coronavirus that was different from those in the United Kingdom and South Africa had been detected from four inbound Japanese passengers from Brazil.
-
The potential targets of Cinda’s layout, these companies are also doing
Time of Update: 2021-04-19
diagnosis of myelodysplastic syndrome (MDS) has been approved by the FDA as a breakthrough therapy. >The second paragraph is EpicentRx's RRx-001. The domestic rights and interests have been exclusively
-
The annual "star" small molecule list is released, including long-acting HIV therapy, PROTAC molecules...
Time of Update: 2021-04-19
The voting results showed that Gilead Sciences' long-acting HIV capsid inhibitor lenacapavir (GS-6207) ranked first, and GlaxoSmithKline (GSK)'s targeted protein degrading agent PROTAC to degrade RIPK2 protein was ranked 6th.
-
Positive Phase 2 Clinical Results of Telomerase Modulator for Treatment of Alzheimer's Disease Released
Time of Update: 2021-04-19
Reference materials:[1] GemVax's highly promising Phase II Alzheimer's disease clinical trial results targeting telomerase published in prestigious Alzheimer's Research & Therapy' journal.
-
Bluestar Genomics' early screening test was recognized by the FDA as a breakthrough medical device
Time of Update: 2021-04-19
One of the reasons why it is difficult to treat is that the symptoms of early pancreatic cancer are mild, and most patients are already at an advanced stage when they are diagnosed.
-
The domestically-made cervical cancer vaccine is listed at only half of the imported adults and only costs about 1,000 yuan for the entire injection.
Time of Update: 2021-04-19
>The manufacturer of this domestic HPV vaccine is Xiamen Wantai Canghai Biotechnology Co. , Ltd. , and its trade name is "Xinkening". The instructions show that the 9 to 14-year-old vaccinators only need to vaccinate twice
-
Chinese experts have made new progress in the field of cerebral hemorrhage research
Time of Update: 2021-04-19
As one of the important developments in the field of cerebral hemorrhage in 2020, the related research results are included in the "2020 Acute Stroke Treatment Progress Special Report" by the international academic journal "Stroke".
-
Roche's Tecentriq first-line treatment of patients with metastatic NSCLC receives positive review from the European Union
Time of Update: 2021-04-19
as the full details of the approval. >If approved, Tecentriq will provide a new treatment plan that will not produce chemotherapy-related adverse reactions. This is also the first and only
-
Some children with epilepsy can be cured and early intervention is better
Time of Update: 2021-04-19
In addition to drug development, eliminating public discrimination against patients with epilepsy is also particularly important for the treatment of the disease.
-
20 years of grinding a sword, "Science" magazine multiple papers reveal the key to HIV vaccine effectiveness
Time of Update: 2021-04-19
A paper published by this university on the 26th found that the CMV vaccine they designed produces an unusual T cell response, which effectively fights SIV in monkeys.
